Treatment of Concurrent Thrombotic Thrombocytopenic Purpura and Graves’ Disease: A Report on Two Cases
Graves’ disease (GD) and thrombotic thrombocytopenic purpura (TTP) are autoimmune diseases caused by autoantibodies against the TSH receptor (TRAb) and the enzyme ADAMTS13. We here report on two patients with concurrent GD and TTP, who achieved sustained remission of both conditions with the TTP tre...
Saved in:
| Main Authors: | Karl Lhotta, Emanuel Zitt, Hannelore Sprenger-Mähr, Lorin Loacker, Alexander Becherer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Case Reports in Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2018/5747969 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early caplacizumab and obinutuzumab enable successful treatment of relapsing thrombotic thrombocytopenic purpura without therapeutic plasma exchange: a case report
by: Judith Schimpf, et al.
Published: (2025-04-01) -
Thrombotic Thrombocytopenic Purpura due to Checkpoint Inhibitors
by: Alexey Youssef, et al.
Published: (2018-01-01) -
Treatment of 36 cases of thrombotic thrombocytopenic purpura
by: Suvajdžić-Vuković Nada D., et al.
Published: (2004-01-01) -
Retained intrauterine device as cause of thrombotic thrombocytopenic purpura
by: Mateusz Klimek, et al.
Published: (2025-07-01) -
Immune thrombotic thrombocytopenic purpura and diabetic ketoacidosis: a case report and literature review
by: Geng-Hao Bai, et al.
Published: (2025-05-01)